Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1748-717X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy ; volume:9 ; number:1 ; day:14 ; month:8 ; year:2014 ; pages:1-9 ; date:12.2014
Radiation oncology ; 9, Heft 1 (14.8.2014), 1-9, 12.2014

Creator: Miwa, Kazuhiro

Contributor: Matsuo, Masayuki
Ogawa, Shin-ichi
Shinoda, Jun
Yokoyama, Kazutoshi
Yamada, Jitsuhiro
Yano, Hirohito
Iwama, Toru
SpringerLink (Online service)

DOI: 10.1186/1748-717X-9-181

URN: urn:nbn:de:1111-2016072620227

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Miwa, Kazuhiro
Matsuo, Masayuki
Ogawa, Shin-ichi
Shinoda, Jun
Yokoyama, Kazutoshi
Yamada, Jitsuhiro
Yano, Hirohito
Iwama, Toru
SpringerLink (Online service)

Other Objects (12)

$Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma$

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma

11C-Methionine uptake in meningiomas after stereotactic radiotherapy

Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]

$Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy$

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy

$Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center$

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions

Improving the stability of 11C–labeled L-methionine with ascorbate

Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction

Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma

Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging

[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions

$Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma$

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma

11C-Methionine uptake in meningiomas after stereotactic radiotherapy

Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]

$Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy$

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy

$Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center$

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions

Improving the stability of 11C–labeled L-methionine with ascorbate

Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction

Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma

Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging

[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions

$Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma$

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma

11C-Methionine uptake in meningiomas after stereotactic radiotherapy

Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]

$Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy$

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy

$Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center$

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions

Improving the stability of 11C–labeled L-methionine with ascorbate

Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction

Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma

Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging

[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma

11C-Methionine uptake in meningiomas after stereotactic radiotherapy

Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions

Improving the stability of 11C–labeled L-methionine with ascorbate

Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction

Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma

Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging

[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma

11C-Methionine uptake in meningiomas after stereotactic radiotherapy

Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions

Improving the stability of 11C–labeled L-methionine with ascorbate

Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction

Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma

Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging

[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma

11C-Methionine uptake in meningiomas after stereotactic radiotherapy

Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions

Improving the stability of 11C–labeled L-methionine with ascorbate

Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction

Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma

Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging

[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions

Related objects

Reset password